Clinical Trial Update: The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) Trial [Phase 3]

View source ↗

Summary

Phase 3 DREAM trial evaluating whether ramipril and rosiglitazone can prevent progression from prediabetes to diabetes and impact cardiovascular risk has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Prediabetes

Drugs mentioned

• Avandia (Rosiglitazone) (Rosiglitazone)
• Ramipril (ramipril)

Snippet

Sponsor: Gerstein, Hertzel, MD | Conditions: Impaired Glucose Tolerance, Cardiovascular Disease | Phase 3 | Status: COMPLETED